About conference

WELCOME FOREWORD:

	Vladimir Shipkov, Executive Director, AIPM Read more...
	Ivan Blanarik, CEO, Boehringer Ingelheim Read more...
	Vitaliy Smerdov, CEO, Sotex Read more...

infor-media Russia is happy to announce start up of the VII International Conference PHARMACEUTICAL BUSINESS IN RUSSIA 2012: WIND OF CHANGE!

MOST IMPORTANT:

300 + participants — top management of the industry, opinion leaders and key news makers all together in a single space
All the aspects of pharmaceutical business: Point of view from the government and business, global and local companies, OTC, Rx, generics and innovative drugs manufactures, distributors and retailers. Business recipes for all the segments!
FRESH! The leading analytic agencies present year in review!
NEW! Panel discussion: pharmaceutical battles
NETWORKING OPPORTUNITY! Use our assistance to arrange discussion with your partners
IN FOCUS! Legal specifics of pharmaceutical business

AGENDA:

State regulation of the industry: changes we should expect
Russian pharmaceutical market: adaptation to turbulence. What will ensure sector growth in the coming years?
Consumption performed by Russians. Prospects for changes in consumer demand
Retail concepts war. Distribution development model. Competition for distributor’s and retailer’s priority
Market growth factors. Flue as hope for growth, will it always be this way?
The Russian model of Market Access
Portfolio prioritisation and portfolio strategy development
Breakfast meeting: leadership practice
Current issues of drug circulation, clinical trials and intellectual property protection

SPEAKERS:

Sergey Tsyb, Director of Chemical-Engineering Complex and Bioengineering Technology Department, Ministry of Economic Development of the Russian Federation

State support of the pharmaceutical industry

Timofey Nizhegorodtsev, Head of Directorate of social sphere and trade control, FAS

Antitrust regulation

Sergey Puzyrevskiy, Head of Legal Directorate, Federal Antimonopoly Service

"The third antimonopoly package" in force

Vladimir Shipkov, Executive Director, AIPM

The honorary chairman of the conference

Alexey Krivoshapko, Director, Prosperity Capital Management

Consumer activity performed by Russians. Forecasts for changes in consumer demand

Stephane Crespel, CEO, Boiron

OTC drugs promotion at the Russian Market

Ivan Blanarik, CEO, Boehringer Ingelheim

Competitive strategy of pharmaceutical manufacturer

Yuriy Litvishcenko, CEO, Chiesi Pharmaceuticals, Deputy Head, Committee for Healthcare and Pharmaceuticals, Association of European Businesses in Russia

Market Access in the current Russian conditions: trends, key aspects, mistakes in realising. Legislation effect

Igor Goryanin, Head of biologic and medical technology cluster, Innovation Centre Skolkovo

Innovative drugs prospects in the Russian market. Prospects of biopharmaceutical clusters development

Marina Veldanova, Head of Rep. Office Russia, Ipsen Pharma

Estimating impact of regulatory changes on the Russian pharmaceutical market

Sergey Beloborodov, Director, Prescription drugs Business Unit, Teva Russia

Rx brand marketing — end of primitive era

Nikolay Zhavoronkov, Deputy Director for marketing and strategic planning, Jadran

Market growth factors. Flue as hope for growth, will it always be this way? The old outlets — crisis or a new development stage?

David Melek-Guseinov, CEO, Cegedim Strategic Data, Chairman of the Expert Board for healthcare, Delovaya Rossiya

Potential drug insurance models

Nikola Milevcic,
Head of Rep. Office in Russia, Grifols, Inc

Launching a new product. New models of original Rx drug promotion at the Russian market

Timofey Petrov,
CEO, Pharm-Sintez

Strategy of a Russian manufacturer of innovative drugs. How to manage a big brand for a small company?

Vitaliy Smerdov,
CEO, Sotex

TBA

Victor Dmitriev,
CEO, ARPM

Herman Inozemtsev, Strategy & Business Development, Director, MBA, Synovate Comcon Healthcare Russia

Naira Adamian,
Director General, Janssen-Cilag Russia

PHARMACEUTICAL "SPARRINGS"

Rustem Muratov,
Vice President for Development,
Rosta Group

Igor Filatov,
CEO,
Protek

Vladimir Boyko,
CCO,
Novartis Consumer Health

Illarion Boyko,
CCO,
NYCOMED: a Takeda Company

Valeria Solok,
CEO,
MC 36.6

Henry Fogels,
Head of Business Division in Russia, Oriola-KD (Distribution company Oriola, pharmacy chains Stary Lekar, Apteka 03)

EVENING RECEPTION "NO TIES"

Evening reception "NO TIES" with David Melik-Guseinov. A story of success. The idea is hopeless if it doesn't seem ridiculous at the first glance.

TARGET AUDIENCE

Top management of Russian and international pharmaceutical manufacturers; chief executive officers of pharmacy chains and distributor companies; representatives of legislative and executive branches of government, controlling market development in federal and regional levels.